In certain cancers especially glioma, mutations of the cytosolic (IDH1) or mitochondrial (IDH2) enzymes create a novel function in which they can further convert α-ketoglutarate to 2-hydroxyglutarate (2-HG) [29]. Here, IDH1 is linked to central nervous system cancer.